Oramed Pharmaceuticals
ORMP
ORMP
22 hedge funds and large institutions have $2.73M invested in Oramed Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 23 → 22 (-1)
71% less call options, than puts
Call options by funds: $9K | Put options by funds: $31K
Holders
22
Holding in Top 10
–
Calls
$9K
Puts
$31K
Top Buyers
| 1 | +$575K | |
| 2 | +$292K | |
| 3 | +$185K | |
| 4 |
Barclays
London,
United Kingdom
|
+$112K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$55.3K |
Top Sellers
| 1 | -$99K | |
| 2 | -$38K | |
| 3 | -$16K | |
| 4 |
JWA
JFS Wealth Advisors
Hermitage,
Pennsylvania
|
-$5K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$4K |